ARTICLE | Company News
Xenogen deal with DuPont
May 10, 2000 7:00 AM UTC
DuPont Pharmaceuticals (Wilmington, Del.) will evaluate Xenogen's in vivo imaging technology, which enables the detection of fluorescent or bioluminescent cells inside living animals. Xenogen (Alameda...